SCHEMBL5987639

SCHEMBL5987639

C=CCOc1ccc(F)c(Br)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CA12 O43570 5/20 0.45
CA1 P00915 5/20 0.45
CA9 Q16790 5/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
KAT6A Q92794 1/20 0.42
ALDH1A1 P00352 3/20 0.40
MAOB P27338 3/20 0.40
HPGD P15428 3/20 0.40
GAA P10253 2/20 0.40
AGER Q15109 1/20 0.40
FGFR1 P11362 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5439339 0.86 MAPT (0.45) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL27957723 0.85 MAPT (0.50) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL4740058 0.80 MAPT (0.46) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL21736912 0.79 ALDH1A1 (0.49) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL10447991 0.79 MEN1 (0.45) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL28036370 0.77 ALDH1A1 (0.52) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL23771636 0.76 AGER (0.53) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL7792853 0.76 ALDH1A1 (0.55) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL22779337 0.76 CA12 (0.44) MAPTMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL28011522 0.76 CA12 (0.46) MAPTMEN1LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045545-B1 Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists ELI LILLY AND COMPANY (US) 2006-05-16 US disclosed
US-6967201-B1 for increasing activation of the 5-HT2C receptor in mammals; treatment of depression, obesity, bulimia, premenstrual syndrome, alcoholism, tobacco abuse, panic disorder ELI LILLY AND COMPANY (US) 2005-11-22 US disclosed
US-6881733-B1 Serotonergic benzofurans ELI LILLY AND COMPANY (US) 2005-04-19 US disclosed
EP-1204659-B1 SEROTONERGIC BENZOFURANS LILLY CO ELI (US) 2003-11-26 EP disclosed
EP-1204654-B1 BENZOFURYLPIPERAZINES: 5-HT2C SEROTONIN RECEPTOR AGONISTS LILLY CO ELI (US) 2003-07-23 EP disclosed
CN-1407982-A Serotonergic benzofurans LILLY CO ELI (US) 2003-04-02 CN disclosed
CN-1365359-A Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists LILLY CO ELI (US) 2002-08-21 CN disclosed
EP-1204659-A2 SEROTONERGIC BENZOFURANS ELI LILLY AND COMPANY (US) 2002-05-15 EP disclosed
EP-1204654-A1 BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS ELI LILLY AND COMPANY (US) 2002-05-15 EP disclosed
EP-1149085-A1 AMINOALKYLBENZOFURANS AS SEROTONIN (5-HT(2C)) AGONISTS ELI LILLY AND COMPANY (US) 2001-10-31 EP disclosed
WO-2001009122-A2 SEROTONERGIC BENZOFURANS ELI LILLY AND COMPANY (US) 2001-02-08 WO disclosed
WO-2001009111-A1 BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS ELI LILLY AND COMPANY (US) 2001-02-08 WO disclosed
WO-2000044737-A1 AMINOALKYLBENZOFURANS AS SEROTONIN (5-HT(2C)) AGONISTS ELI LILLY AND COMPANY (US) 2000-08-03 WO disclosed